Abstract
Autoimmune liver diseases (AILDs) have an important genetic background. This is supported by different lines of evidence, that is, clustering in families, high concordance rates in monozygotic twins, increased risk of the disease in siblings compared to general population, and association with other autoimmune conditions. In this chapter, we summarize current knowledge regarding each of the three most common AILDs (autoimmune hepatitis, AIH; primary biliary cholangitis, PBC; and primary sclerosing cholangitis, PSC); we then propose a series of possible future lines of investigation to explore the amount of heritability, which is still to be determined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol [Internet] 1994;20(6):698–701. Available from: https://doi.org/10.1016/S0168-8278(05)80137-0
Grønbæk L, Vilstrup H, Pedersen L, Christensen K, Jepsen P. Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study. J Hepatol [Internet] 2018;69(4):873–7. Available from: https://doi.org/10.1016/j.jhep.2018.05.035
Selmi C, Mayo MJ, Bach N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004;127(2):485–92.
Jones DEJ, Watt FE, Metcalf J V, Bassendine MF, James OFW. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol [Internet] 1999;30(3):402–7. Available from: https://doi.org/10.1016/S0168-8278(99)80097-X
Floreani A, Franceschet I, Cazzagon N, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol [Internet] 2015;48(2–3):192–7. Available from: http://link.springer.com/10.1007/s12016-014-8427-x
Grønbæk L, Vilstrup H, Pedersen L, Jepsen P. Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: a Danish nationwide cohort study. Liver Int [Internet] 2019;39(1):205–14. Available from: https://doi.org/10.1111/liv.13963
Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis – a comprehensive review. J Hepatol [Internet] 2017;67(6):1298–323. Available from: https://doi.org/10.1016/j.jhep.2017.07.022
Lander ES, Schork NJ. Genetic dissection of complex traits. Science (80- ) [Internet] 1994;265(5181):2037 LP–2048. Available from: http://science.sciencemag.org/content/265/5181/2037.abstract
Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science (80- ) [Internet] 1996;273(5281):1516 LP – 1517. Available from: http://science.sciencemag.org/content/273/5281/1516.abstract
Feero WG, Guttmacher AE, Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med [Internet] 2010;363(2):166–76. Available from: http://www.nejm.org/doi/full/10.1056/NEJMra0905980%5Cn; http://www.nejm.org/doi/abs/10.1056/NEJMra0905980%5Cn; http://www.nejm.org.ezproxy.umassmed.edu/doi/full/10.1056/NEJMra0905980
Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med [Internet] 2010;363(2):166–76. Available from: https://doi.org/10.1056/NEJMra0905980
Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol [Internet] 2018;18:325. Available from: https://doi.org/10.1038/nri.2017.143
Homberg J-C, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of “autoimmune” hepatitis. Hepatology [Internet] 1987;7(6):1333–9. Available from: https://doi.org/10.1002/hep.1840070626
Strettell MD, Donaldson PT, Thomson LJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology [Internet] 1997;112(6):2028–35. Available from: https://doi.org/10.1053/gast.1997.v112.pm9178696
Doherty DG, Donaldson PT, Underhill JA, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology [Internet] 1994;19(3):609–15. Available from: https://doi.org/10.1002/hep.1840190311
Mackay I, Morris P. Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet [Internet] 1972;300(7781):793–5. Available from: http://www.sciencedirect.com/science/article/pii/S0140673672921496
Opelz G, Vogten AJM, Summerskill WHJ, Schalm SW, Terasaki PI. HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosis. Tissue Antigens [Internet] 1977;9(1):36–40. Available from: https://doi.org/10.1111/j.1399-0039.1977.tb01077.x
Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology [Internet] 1991 [cited 2016 Jul 15];13(4):701–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2010165
Seki T, Ota M, Furuta S, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology [Internet] 1992;103(3):1041–7. Available from: https://www.gastrojournal.org/article/0016-5085(92)90041-V/abstract
Vázquez-García MN, Aláez C, Olivo A, et al. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol [Internet] 1998;28(6):985–90. Available from: https://doi.org/10.1016/S0168-8278(98)80347-4
Pando M, Larriba J, Fernandez GC, et al. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology [Internet] 1999;30(6):1374–80. Available from: https://doi.org/10.1002/hep.510300611
de Boer YS, van Gerven NMF, Zwiers A, et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology [Internet] 2014;147(2):443–452.e5. Available from: https://doi.org/10.1053/j.gastro.2014.04.022
Group TIPBCGS, Juran BD, Lammert C, et al. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet [Internet] 2012;21(23):5209–21. Available from: https://doi.org/10.1093/hmg/dds359
Liu JZ, Hov JR, Folseraas T, et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet [Internet] 2013;45:670. Available from: https://doi.org/10.1038/ng.2616
Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet [Internet] 2008;40(4):395–402. Available from: https://doi.org/10.1038/ng.102
Umemura T, Joshita S, Hamano H, et al. Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients. J Hum Genet [Internet] 2017;62(11):963–7. Available from: https://doi.org/10.1038/jhg.2017.74
Chaouali M, Fernandes V, Ghazouani E, Pereira L, Kochkar R. Association of STAT4, TGFβ1, SH2B3 and PTPN22 polymorphisms with autoimmune hepatitis. Exp Mol Pathol [Internet] 2018;105(3):279–84. Available from: http://www.sciencedirect.com/science/article/pii/S0014480018301837
Devallière J, Charreau B. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol [Internet] 2011;82(10):1391–402. Available from: http://www.sciencedirect.com/science/article/pii/S0006295211004060
Mori T, Iwasaki Y, Seki Y, et al. Lnk/Sh2b3 controls the production and function of dendritic cells and regulates the induction of IFN-γ–producing T cells. J Immunol [Internet] 2014;193(4):1728 LP – 1736. Available from: http://www.jimmunol.org/content/193/4/1728.abstract
Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and Hla risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol [Internet] 2002;97(2). Available from: https://journals.lww.com/ajg/Fulltext/2002/02000/Antibodies_To_Soluble_Liver_Antigen_Liver_Pancreas.34.aspx
Jones DEJ, Watt FE, Metcalf JV, Bassendine MF, James OFW. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol. 1999;30(3):402–7.
Farh KK-H, Marson A, Zhu J, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature [Internet] 2014;518:337. Available from: https://doi.org/10.1038/nature13835
Hirschfield GM, Liu X, Xu C, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med [Internet] 2009;360(24):2544–55. Available from: https://doi.org/10.1056/NEJMoa0810440
Hirschfield GM, Liu X, Han Y, et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet [Internet] 2010;42:655. Available from: https://doi.org/10.1038/ng.631
Liu X, Invernizzi P, Lu Y, et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet [Internet] 2010;42(8):658–60. Available from: https://doi.org/10.1038/ng.627
Mells GF, Floyd JAB, Morley KI, et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet [Internet] 2011;43:329. Available from: https://doi.org/10.1038/ng.789
Nakamura M, Nishida N, Kawashima M, et al. Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet [Internet] 2012;91(4):721–8. Available from: https://doi.org/10.1016/j.ajhg.2012.08.010
Qiu F, Tang R, Zuo X, et al. A genome-wide association study identifies six novel risk loci for primary biliary cholangitis. Nat Commun 2017;14828.
Juran BD, Hirschfield GM, Invernizzi P, et al. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet. 2012;21(23):5209–21.
Liu JZ, Almarri MA, Gaffney DJ, et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet [Internet] 2012;44:1137. Available from: https://doi.org/10.1038/ng.2395
Cordell HJ, Han Y, Mells GF, et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat Commun [Internet] 2015;6:8019. Available from: http://www.nature.com/ncomms/2015/150922/ncomms9019/full/ncomms9019.html%5Cn; http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4580981&tool=pmcentrez&rendertype=abstract%5Cn; http://www.nature.com/doifinder/10.1038/ncomms9019
Donaldson PT, Baragiotta A, Heneghan MA, et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology [Internet] 2006;44(3):667–74. Available from: https://doi.org/10.1002/hep.21316
Invernizzi P, Selmi C, Poli F, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology [Internet] 2008;48(6):1906–12. Available from: https://doi.org/10.1002/hep.22567
Li M, Zheng H, Tian Q, Rui M, Liu D. HLA-DR polymorphism and primary biliary cirrhosis: evidence from a meta-analysis. Arch Med Res [Internet] 2014;45(3):270–9. Available from: http://www.sciencedirect.com/science/article/pii/S018844091400040X
Clemente MG, Frau F, Bernasconi M, et al. Distinctive HLA-II association with primary biliary cholangitis on the Island of Sardinia. United Eur Gastroenterol J [Internet] 2017;5(4):527–31. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28588884
Gulamhusein AF, Juran BD, Lazaridis KN. Genome-wide association studies in primary biliary cirrhosis. Semin Liver Dis. 2015;35(4):392–401.
Ji SG, Juran BD, Mucha S, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet [Internet] 2017;49(2):269–73. Available from: https://doi.org/10.1038/ng.3745
Srivastava B, Mells GF, Cordell HJ, et al. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis. Scand J Gastroenterol. 2012;47(7):820–6.
Melum E, Franke A, Schramm C, et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet [Internet] 2010;43:17. Available from: https://doi.org/10.1038/ng.728
Ellinghaus D, Jostins L, Spain SL, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. 2016;48(5):510–8.
Ellinghaus D, Folseraas T, Holm K, et al. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology. 2013;58(3):1074–83.
Folseraas T, Melum E, Rausch P, et al. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol [Internet] 2012;57(2):366–75. Available from: https://doi.org/10.1016/j.jhep.2012.03.031
Couturier N, Bucciarelli F, Nurtdinov RN, et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain [Internet] 2011;134(3):693–703. Available from: https://doi.org/10.1093/brain/awr010
Hsu W, Zhang W, Tsuneyama K, et al. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Rα−/− mice. Hepatology [Internet] 2009;49(1):133–40. Available from: https://doi.org/10.1002/hep.22591
Ronca V, Chen QB, Lygoura V, et al. Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency. J Dig Dis [Internet] 2019;20(7):363–70. Available from: https://doi.org/10.1111/1751-2980.12790
Hirschfield GM, Gershwin ME, Strauss R, et al. Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study. Hepatology [Internet] 2016;64(1):189–99. Available from: https://doi.org/10.1002/hep.28359
Jiang X, Karlsen TH. Genetics of primary sclerosing cholangitis and pathophysiological implications [Internet]. Nat. Rev. Gastroenterol. Hepatol. 2017;14(5):279–95. Available from: https://doi.org/10.1038/nrgastro.2016.154
Ji S-G, Juran BD, Mucha S, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet [Internet] 2016 [cited 2017 Dec 10];49(2):269–73. Available from: http://www.nature.com/doifinder/10.1038/ng.3745
Spurkland A, Saarinen S, Boberg KM, et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens [Internet] 1999;53(5):459–69. Available from: https://doi.org/10.1034/j.1399-0039.1999.530502.x
Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology [Internet] 1991;13(1):129–33. Available from: https://doi.org/10.1002/hep.1840130119
Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity [Internet] 2002;35(8):555–64. Available from: https://doi.org/10.1080/0891693021000054093
McElroy JP, Cree BAC, Caillier SJ, et al. Refining the association of MHC with multiple sclerosis in African Americans. Hum Mol Genet [Internet] 2010;19(15):3080–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20466734
Krawczyk M, Höblinger A, Mihalache F, et al. Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma. Dig Liver Dis [Internet] 2013;45(7):612–5. Available from: https://doi.org/10.1016/j.dld.2012.12.017
Fiorotto R, Scirpo R, Trauner M, et al. Loss of CFTR Affects Biliary Epithelium Innate Immunity and Causes TLR4–NF-κB–Mediated Inflammatory Response in Mice. Gastroenterology [Internet] 2011;141(4):1498–1508.e5. Available from: https://doi.org/10.1053/j.gastro.2011.06.052
Shearn CT, Fennimore B, Orlicky DJ, et al. Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response. Free Radic Biol Med [Internet] 2019;143:101–14. Available from: http://www.sciencedirect.com/science/article/pii/S0891584919301601
Wagner J, Catto-Smith AG, Cameron DJS, Kirkwood CD. Pseudomonas infection in children with early-onset Crohn’s disease: an association with a mutation close to PSMG1. Inflamm Bowel Dis [Internet] 2012;19(4):E58–9. Available from: https://doi.org/10.1002/ibd.23017
Sebode M, Peiseler M, Franke B, et al. Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms. J Hepatol [Internet] 2014;60(5):1010–6. Available from: https://doi.org/10.1016/j.jhep.2013.12.027
Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol [Internet] 2008;9(2):176–85. Available from: https://doi.org/10.1038/ni1554
Herro R, Da Silva Antunes R, Aguilera AR, Tamada K, Croft M. Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis. J Allergy Clin Immunol [Internet] 2015;136(3):757–68. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25680454
Trivedi PJ, Tickle J, Vesterhus MN, et al. Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner. Gut [Internet] 2018;67(6):1135 LP–1145. Available from: http://gut.bmj.com/content/67/6/1135.abstract
Zimmermann HW, Seidler S, Gassler N, et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One [Internet] 2011;6. Available from: https://doi.org/10.1371/journal.pone.0021381
Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature [Internet] 2009;461(7265):747–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19812666%0A; http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2831613
Sadee W, Hartmann K, Seweryn M, Pietrzak M, Handelman SK, Rempala GA. Missing heritability of common diseases and treatments outside the protein-coding exome. Hum Genet 2014;133(10):1199–215.
Maroilley T, Tarailo-Graovac M. Uncovering missing heritability in rare diseases. Genes (Basel). 2019;10(4):275.
Tang R, Chen H, Miao Q, et al. The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk. Genes Immun [Internet] 2015;16:193. Available from: https://doi.org/10.1038/gene.2014.76
Jiang X, Karlsen TH. Genetics of primary sclerosing cholangitis and pathophysiological implications. Nat Rev Gastroenterol Hepatol [Internet] 2017;14(5):279–95. Available from: http://www.nature.com/doifinder/10.1038/nrgastro.2016.154
Génin E. Missing heritability of complex diseases: case solved? Hum Genet [Internet] 2019;(0123456789). Available from: http://link.springer.com/10.1007/s00439-019-02034-4
Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci. 2012;109, 1193(4):–8.
Wise AL, Gyi L, Manolio TA. eXclusion: toward integrating the X chromosome in genome-wide association analyses. Am J Hum Genet [Internet] 2013;92(5):643–7. Available from: https://doi.org/10.1016/j.ajhg.2013.03.017
Amberger J, Bocchini CA, Scott AF, Hamosh A. McKusick’s Online Mendelian Inheritance in Man (OMIM®). Nucleic Acids Res [Internet] 2008;37(suppl_1):D793–6. Available from: https://doi.org/10.1093/nar/gkn665
MacArthur J, Bowler E, Cerezo M, et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res [Internet] 2016;45(D1):D896–901. Available from: https://doi.org/10.1093/nar/gkw1133
Invernizzi P. The X chromosome in female-predominant autoimmune diseases. Ann N Y Acad Sci [Internet] 2007;1110(1):57–64. Available from: https://doi.org/10.1196/annals.1423.007
Sybert VP, Mccauley E. Turner’s Syndrome. N Engl J Med 2004;1227–38.
Invernizzi P, Miozzo M, Battezzati PM, et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet. 2004;363, 533(9408):–5.
Invernizzi P, Miozzo M, Selmi C, et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol [Internet] 2005;175(1):575–8. Available from: http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.175.1.575
Gerussi A, Cristoferi L, Carbone M, Asselta R, Invernizzi P. The immunobiology of female predominance in primary biliary cholangitis. J Autoimmun [Internet] 2018;95(October):124–32. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0896841118305936
Gao F, Chang D, Biddanda A, et al. XWAS: a software toolset for genetic data analysis and association studies of the X chromosome. J Hered 2015;106(5):666–71.
Strachan T. Genetics and genomics in medicine. 2015.
Juran BD, Atkinson EJ, Larson JJ, et al. Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction. Hepatology. 2010;52(1):223–9.
Sun X, Lu Q, Mukheerjee S, Crane PK, Elston R, Ritchie MD. Analysis pipeline for the epistasis search – statistical versus biological filtering. Front Genet. 2014;5(APR):1–7.
Howel D, Fischbacher CM, Bhopal RS, Gray J, Metcalf JV, James OFW. An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology. 2000;31(5):1055–60.
Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JMT, Brumfitt W, Sherlock S. Bacteriuria and primary biliary cirrhosis. Gut. 1984;25(study IV):133–7.
Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol [Internet] 2013;8(Il):303–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23347352
Hormone-dependent MD, Markle JGM, Frank DN, et al. Sex differences in the gut. Science (80- ). 2013;339(March):1084–8.
Tang R, Wei Y, Li Y, et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut [Internet] 2018;67(3):534 LP – 541. Available from: http://gut.bmj.com/content/67/3/534.abstract
Wei Y, Li Y, Yan L, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut 2019;1–9.
Quraishi MN, Sergeant M, Kay G, et al. The gut-adherent microbiota of PSC-IBD is distinct to that of IBD. Gut [Internet] 2017;66(2):386–8. Available from: http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2016-311915
Manfredo Vieira S, Hiltensperger M, Kumar V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science (80- ) [Internet] 2018;359(6380):1156–61. Available from: http://www.sciencemag.org/lookup/doi/10.1126/science.aar7201
Zhang P, Lu Q. Genetic and epigenetic influences on the loss of tolerance in autoimmunity. Cell Mol Immunol [Internet] 2018;(October 2017):1–11. Available from: http://www.nature.com/doifinder/10.1038/cmi.2017.137
Carnero-Montoro E, Alarcón-Riquelme ME. Epigenome-wide association studies for systemic autoimmune diseases: the road behind and the road ahead. Clin Immunol [Internet] 2018;(March):1–13. Available from: https://doi.org/10.1016/j.clim.2018.03.014
Mok A, Solomon O, Nayak RR, et al. Genome-wide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responses. Lupus Sci Med [Internet] 2016;3(1):e000183. Available from: http://lupus.bmj.com/lookup/doi/10.1136/lupus-2016-000183
Altorok N, Coit P, Hughes T, et al. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren’s syndrome. Arthritis Rheumatol [Internet] 2014;66(3):731–9. Available from: http://doi.wiley.com/10.1002/art.38264
Glossop JR, Emes RD, Nixon NB, et al. Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations. Epigenetics. 2014;9(9):1228–37.
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol [Internet] 2016;16:626. Available from: https://doi.org/10.1038/nri.2016.90
Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol [Internet] 2010;10:594. Available from: https://doi.org/10.1038/nri2815
Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex? Autoimmun Rev. 2008;7(8):626–30.
Tukiainen T, Villani A-C, Yen A, et al. Landscape of X chromosome inactivation across human tissues. Nature [Internet] 2017;550:244. Available from: https://doi.org/10.1038/nature24265
Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature [Internet] 2005;434:400. Available from: https://doi.org/10.1038/nature03479
Takeno M, Nagafuchi H, Kaneko S, et al. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J Immunol [Internet] 1997;158(7):3529 LP – 3538. Available from: http://www.jimmunol.org/content/158/7/3529.abstract
Zeynep Ö, Sevgi B, Sedat K, et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum [Internet] 2005;52(5):1564–70. Available from: https://doi.org/10.1002/art.21026
Miozzo M, Selmi C, Gentilin B, et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology. 2007;46(2):456–62.
Lleo A, Liao J, Invernizzi P, et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology. 2012;55(1):153–60.
Esteller M. Non-coding RNAs in human disease. Nat Rev Genet [Internet] 2011;12(12):861–74. Available from: https://doi.org/10.1038/nrg3074
Migita K, Komori A, Kozuru H, et al. Circulating microRNA profiles in patients with Type-1 autoimmune hepatitis. PLoS One [Internet] 2015;10(11):e0136908. Available from: https://doi.org/10.1371/journal.pone.0136908
Rodrigues PM, Perugorria MJ, Santos-Laso A, Bujanda L, Beuers U, Banales JM. Primary biliary cholangitis: a tale of epigenetically-induced secretory failure? J Hepatol [Internet] 2018.;Available from: http://www.sciencedirect.com/science/article/pii/S0168827818323626
Bernuzzi F, Marabita F, Lleo A, et al. Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Clin Exp Immunol [Internet] 2016;185(1):61–71. Available from: https://doi.org/10.1111/cei.12776
Banales JM, Sáez E, Úriz M, et al. Up-regulation of microRNA 506 leads to decreased Cl -/HCO 3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology. 2012;56(2):687–97.
Hublin JJ. The origin of Neanderthals. Proc Natl Acad Sci U S A [Internet] 2009;106(38):16022–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19805257
Green, R.E., Krause, J., Briggs, A., W., Maricic, T., Stenzel, U., Kircher, M., Patterson, N., Li, H., Zhai, W., Fritz, M.H., Hansen, N.F., Durand, E., Y., Malaspinas, A., Jensen, J., D., Marques-Bonet, T., Alkan, C., Prüfer, K., Meyer, M., Burbano HA. A Draft sequence of the neandertal genome. Science [Internet] 2010;328(5979):710–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20448178
Sankararaman S, Mallick S, Dannemann M, et al. The genomic landscape of Neanderthal ancestry in present-day humans. Nature [Internet] 2014;507:354. Available from: https://doi.org/10.1038/nature12961
Vernot B, Akey JM. Resurrecting surviving Neandertal lineages from modern human genomes. Science (80- ) [Internet] 2014;343(6174):1017 LP – 1021. Available from: http://science.sciencemag.org/content/343/6174/1017.abstract
Reich D, Patterson N, Kircher M, et al. Denisova admixture and the first modern human dispersals into Southeast Asia and Oceania. Am J Hum Genet. 2011;89(4):516–28.
Slon V, Mafessoni F, Vernot B, et al. The genome of the offspring of a Neanderthal mother and a Denisovan father. Nature [Internet] 2018;561(7721):113–6. Available from: https://doi.org/10.1038/s41586-018-0455-x
Jacobs GS, Hudjashov G, Saag L, et al. Multiple Deeply Divergent Denisovan Ancestries in Papuans. Cell [Internet] 2019.;Available from: https://doi.org/10.1016/j.cell.2019.02.035
Dannemann M, Andrés AM, Kelso J. Introgression of Neandertal- and Denisovan-like haplotypes contributes to adaptive variation in human toll-like receptors. Am J Hum Genet. 2016;98, 22(1):–33.
Enard D, Petrov DA. Evidence that RNA viruses drove adaptive introgression between Neanderthals and modern humans. Cell [Internet] 2018;175(2):360–371.e13. Available from: https://doi.org/10.1016/j.cell.2018.08.034
Consortium TST 2 D, Williams AL, Jacobs SBR, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature [Internet] 2013;506:97. Available from: https://doi.org/10.1038/nature12828
Schrider DR, Kern AD. Supervised machine learning for population genetics: a new paradigm. Trends Genet [Internet] 2018;34(4):301–12. Available from: https://doi.org/10.1016/j.tig.2017.12.005
Ho DSW, Schierding W, Wake M, Saffery R, O’Sullivan J. Machine learning SNP based prediction for precision medicine. Front Genet [Internet] 2019;10(March):1–10. Available from: https://www.frontiersin.org/article/10.3389/fgene.2019.00267/full
Grabowski P, Rappsilber J. A primer on data analytics in functional genomics: how to move from data to insight? Trends Biochem Sci [Internet] 2019;44(1):21–32. Available from: https://doi.org/10.1016/j.tibs.2018.10.010
Okser S, Pahikkala T, Airola A, Salakoski T, Ripatti S, Aittokallio T. Regularized machine learning in the genetic prediction of complex traits. PLoS Genet [Internet] 2014;10(11):e1004754. Available from: https://dx.plos.org/10.1371/journal.pgen.1004754
Cordell HJ. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet. 2009;10(6):392–404.
Zou J, Huss M, Abid A, Mohammadi P, Torkamani A, Telenti A. A primer on deep learning in genomics. Nat Genet [Internet] 2019;51(1):12–8. Available from: https://doi.org/10.1038/s41588-018-0295-5
Mells GF, Kaser A, Karlsen TH. Novel insights into autoimmune liver diseases provided by genome-wide association studies. J Autoimmun. 2013;46:41–54.
Joshita S, Umemura T, Tanaka E, Ota M. Genetics and epigenetics in the pathogenesis of primary biliary cholangitis. Clin J Gastroenterol. 2018;11(1):11–8.
Kawashima M, Hitomi Y, Aiba Y, et al. Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population. Hum Mol Genet [Internet] 2017;26(3):650–9. Available from: https://doi.org/10.1093/hmg/ddw406
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gerussi, A., Carbone, M., Asselta, R., Invernizzi, P. (2020). Genetics of Autoimmune Liver Diseases. In: Gershwin, M.E., M. Vierling, J., Tanaka, A., P. Manns, M. (eds) Liver Immunology . Springer, Cham. https://doi.org/10.1007/978-3-030-51709-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-51709-0_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51708-3
Online ISBN: 978-3-030-51709-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)